BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35403909)

  • 1. [Importance of surgery in distant metastatic pancreatic neuroendocrine neoplasms].
    Billmann F; Nießen A; Hackert T
    Chirurgie (Heidelb); 2022 Aug; 93(8):758-764. PubMed ID: 35403909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal therapy with aggressive hepatectomy, everolimus, and octreotide for metastatic pancreatic neuroendocrine neoplasm enables 10-year survival.
    Yumoto S; Nakagawa S; Hayashi H; Ogawa D; Shiraishi Y; Sato H; Matsumoto T; Imai K; Yamashita YI; Baba H
    Clin J Gastroenterol; 2022 Dec; 15(6):1136-1144. PubMed ID: 36038805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic surgery for metastases from neuroendocrine tumors.
    Sarmiento JM; Que FG
    Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the surgical landscape of pancreatic neuroendocrine neoplasia in Austria: Results from the ASSO pNEN study group.
    Primavesi F; Klieser E; Cardini B; Marsoner K; Fröschl U; Thalhammer S; Fischer I; Hauer A; Urbas R; Kiesslich T; Neureiter D; Zitt M; Klug R; Wundsam H; Sellner F; Karner J; Függer R; Cakar-Beck F; Kornprat P; Öfner D; Stättner S;
    Eur J Surg Oncol; 2019 Feb; 45(2):198-206. PubMed ID: 30262324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas - a single center experience with ten patients.
    Lang H; Schlitt HJ; Schmidt H; Flemming P; Nashan B; Scheumann GF; Oldhafer KJ; Manns MP; Raab R
    Langenbecks Arch Surg; 1999 Aug; 384(4):370-7. PubMed ID: 10473858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [SURGICAL TREATMENT OF METASTATIC NON—FUNCTIONING NEUROENDOCRINE TUMORS OF THE PANCREAS].
    Shkarban VP
    Klin Khir; 2016; (7):5-7. PubMed ID: 30256557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sporadic pancreatic neuroendocrine neoplasms: A retrospective clinicopathological and outcome analysis from a Latvian study group.
    Ptasnuka M; Truskovs A; Ozolins A; Narbuts Z; Sperga M; Plaudis H
    Front Surg; 2023; 10():1131333. PubMed ID: 37021091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resection of Non-Functional Pancreatic Neuroendocrine Neoplasms-A Single-Center Retrospective Outcome Analysis.
    Lindner K; Binte D; Hoeppner J; Wellner UF; Schulte DM; Schmid SM; Luley K; Buchmann I; Tharun L; Keck T; Gebauer J; Kulemann B
    Curr Oncol; 2021 Aug; 28(4):3071-3080. PubMed ID: 34436034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A wait-and-watch approach to small pancreatic neuroendocrine tumors: prognosis and survival.
    Massironi S; Rossi RE; Zilli A; Casazza G; Ciafardini C; Conte D
    Oncotarget; 2016 Apr; 7(14):18978-83. PubMed ID: 26959887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curative and palliative surgery in patients with neuroendocrine tumors of the gastro-entero-pancreatic (GEP) tract.
    Goretzki PE; Mogl MT; Akca A; Pratschke J
    Rev Endocr Metab Disord; 2018 Jun; 19(2):169-178. PubMed ID: 30280290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas.
    Galleberg RB; Knigge U; Tiensuu Janson E; Vestermark LW; Haugvik SP; Ladekarl M; Langer SW; Grønbæk H; Österlund P; Hjortland GO; Assmus J; Tang L; Perren A; Sorbye H
    Eur J Surg Oncol; 2017 Sep; 43(9):1682-1689. PubMed ID: 28522174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ki-67 and presence of liver metastases identify different progression-risk classes in pancreatic neuroendocrine neoplasms (pNEN) undergoing resection.
    Milione M; Maisonneuve P; Pellegrinelli A; Spaggiari P; Centonze G; Coppa J; Delconte G; Droz Dit Busset M; Lanhazo O; Pruneri G; Mazzaferro V
    Eur J Surg Oncol; 2019 May; 45(5):755-760. PubMed ID: 30366875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Indications for the Surgical Management of Pancreatic Neuroendocrine Neoplasms].
    Bösch F; Belyaev O; Brunner M; Müller-Debus CF; ; Grützmann R; Keck T; Uhl W; Witzigmann H; Werner J
    Zentralbl Chir; 2020 Aug; 145(4):365-373. PubMed ID: 32599635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?
    Merola E; Rinke A; Partelli S; Gress TM; Andreasi V; Kollár A; Perren A; Christ E; Panzuto F; Pascher A; Jann H; Arsenic R; Cremer B; Kaemmerer D; Kump P; Lipp RW; Agaimy A; Wiedenmann B; Falconi M; Pavel ME
    Ann Surg Oncol; 2020 May; 27(5):1348-1355. PubMed ID: 31720931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].
    Auernhammer CJ; Jauch KW; Hoffmann JN
    Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in survival for patients with resectable versus unresectable metastases from pancreatic islet cell cancer.
    House MG; Cameron JL; Lillemoe KD; Schulick RD; Choti MA; Hansel DE; Hruban RH; Maitra A; Yeo CJ
    J Gastrointest Surg; 2006 Jan; 10(1):138-45. PubMed ID: 16368504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological Characteristics of Nonfunctional Pancreatic Neuroendocrine Neoplasms and the Effect of Surgical Treatment on the Prognosis of Patients with Liver Metastases: A Study Based on the SEER Database.
    Sadula A; Li G; Xiu D; Ye C; Ren S; Guo X; Yuan C
    Comput Math Methods Med; 2022; 2022():3689895. PubMed ID: 35720036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgery for Pancreatic Neuroendocrine Tumor G3 and Carcinoma G3 Should be Considered Separately.
    Yoshida T; Hijioka S; Hosoda W; Ueno M; Furukawa M; Kobayashi N; Ikeda M; Ito T; Kodama Y; Morizane C; Notohara K; Taguchi H; Kitano M; Yane K; Tsuchiya Y; Komoto I; Tanaka H; Tsuji A; Hashigo S; Mine T; Kanno A; Murohisa G; Miyabe K; Takagi T; Matayoshi N; Sakaguchi M; Ishii H; Kojima Y; Matsuo K; Yoshitomi H; Nakamori S; Yanagimoto H; Yatabe Y; Furuse J; Mizuno N
    Ann Surg Oncol; 2019 May; 26(5):1385-1393. PubMed ID: 30863939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical management of pancreatic neuroendocrine tumors.
    Kimura W; Tezuka K; Hirai I
    Surg Today; 2011 Oct; 41(10):1332-43. PubMed ID: 21922354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.